Alphatec now expects to end the year with $472 million in revenue, up from its second quarter prediction of $462 million, according to an Oct. 16 press release.
Its surgical revenue at the end of the quarter was between $103.3 million and $103.9 million, up from $102 million in quarter two.
Its total revenue reached $117.7 million to $118.5 million, up from $117 million in quarter two.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
